<DOC>
	<DOCNO>NCT00855686</DOCNO>
	<brief_summary>The purpose exploratory study determine whether memantine provide benefit clinical symptom patient Parkinson 's Disease Dementia Dementia Lewy Bodies .</brief_summary>
	<brief_title>Memantine Versus Placebo Parkinson 's Disease Dementia Dementia With Lewy Bodies</brief_title>
	<detailed_description>The objective exploratory study assess benefit memantine compare placebo out-patients diagnosis Parkinson 's Disease Dementia Dementia Lewy Bodies ( mild moderate severity ) 6-month period . This multinational , randomised , double-blind , parallel-group , placebo-controlled , fixed-dose study specific cognitive ( attention , executive function , visual perception memory ) , behavioural , functional global measure .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>The study population consist male female outpatient least 50 year age mild moderate disease severity ( MMSE 12 24 inclusive ) accord UKPDS DSM IV TR criterion ( PDD patient ) third report DLB consortium ( DLB patient ) knowledgeable reliable caregiver accompany patient clinic visit course study . Evidence clinically significant active disease , evidence neurological disorder , current treatment AChEIs .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Memantine</keyword>
	<keyword>Cognition</keyword>
	<keyword>Parkinson 's Disease Dementia</keyword>
	<keyword>Dementia With Lewy Bodies</keyword>
</DOC>